First American Bank’s Pacific Biosciences PACB Stock Holding History

First American Bank’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-26,720	Closed	-$239K	–	333
2016 Q3	$239K	Sell	26,720 -700	-3%	-$5.85K	0.02%	311
2016 Q2	$193K	Sell	27,420 -845	-3%	-$7.72K	0.02%	301
2016 Q1	$240K	Buy	28,265 +1,700	+6%	+$16.7K	0.02%	274
2015 Q4	$349K	Buy	+26,565	New	+$238K	0.04%	172

Other funds holding PACB

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

First American Bank's PACB Position: Q4 2016 in Review

First American Bank sold out of Pacific Biosciences (PACB) in Q4 2016, closing a stake of 26,720 shares — an estimated $239K sold.

First American Bank first reported a position in PACB in Q4 2015 and held it in 4 quarters. The position peaked at $349K in Q4 2015. 115 funds tracked by Wall St. Rank hold PACB as of Q4 2016.

First American Bank reported no remaining Pacific Biosciences position as of Q4 2016 after selling out during the quarter.
First American Bank sold 26,720 Pacific Biosciences shares in Q4 2016, an estimated $239K.
First American Bank first reported a position in Pacific Biosciences in Q4 2015 and held it in 4 quarters.
First American Bank's Pacific Biosciences position peaked at $349K in Q4 2015.
115 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2016.

Based on First American Bank's 13F filing for Q4 2016, filed 20 Jan 2017.